The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zithromax Powder for Oral Suspension 200mg/5ml



Pfizer Healthcare IrelandPA0822/191/002

Main Information

Trade NameZithromax Powder for Oral Suspension 200mg/5ml
Active SubstancesAzithromycin
Dosage FormPowder for oral suspension
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/191/002

Group Information

ATC CodeJ01FA Macrolides
J01FA10 azithromycin

Status

License statusAuthorised
Licence Issued18/02/1992
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back